P-ISSN 2587-2400 | E-ISSN 2587-196X
EJMO. 2017; 1(2): 115-117 | DOI: 10.14744/ejmo.2017.10820

Sunitinib-Associated Acute Pancreatitis: A Case Report

Melek Karakurt Eryilmaz1, Fatma Yalcin Musri1, Derya Kivrak Salim1, Gokhan Tazegul2, Hasan Senol Coskun1
1Department of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya, Turkey, 2Department of Internal Medicine, Akdeniz University Faculty of Medicine, Antalya, Turkey

Sunitinib is a multikinase inhibitor used for the treatment of metastatic renal cell carcinoma. Acute pancreatitis associated with sunitinib is rare. Presently described is a case of a 79-year-old man with metastatic renal cell carcinoma who developed acute pancreatitis following the initiation sunitinib treatment. The development of acute pancreatitis secondary to sunitinib should be considered in patients presenting with abdominal pain after the administration of sunitinib.


Cite This Article

Karakurt Eryilmaz M, Yalcin Musri F, Kivrak Salim D, Tazegul G, Coskun H. Sunitinib-Associated Acute Pancreatitis: A Case Report. EJMO. 2017; 1(2): 115-117

Corresponding Author: Karakurt Eryilmaz M.

Full Text PDF